奥罗普切病毒:一种新发神经侵袭性虫媒病毒
奥罗普切病毒(OROV)是南美、中美和加勒比地区流行的虫媒病毒,近期在古巴出现并输入美国和欧洲。约60%感染者有症状,表现为突发发热和流感样疾病,可呈双相病程,疑似可垂直传播。动物模型显示神经侵袭,人类已报告脑膜炎、脑炎和围感染期吉兰-巴雷综合征。诊断依靠检测核酸、IgM或中和抗体,无抗病毒药物和疫苗,防蚊媒叮咬是关键。
要点
- OROV在古巴新发,美国和欧洲已有旅行输入病例。
- 约60%感染有症状,突发发热和流感样疾病,可双相复发。
- 动物模型显示神经侵袭,人类有脑膜炎、脑炎和吉兰-巴雷综合征报告。
核心结论
- OROV是一种新发神经侵袭性虫媒病毒,neurologists应认识并向当地/州/领地卫生部门报告潜在神经侵袭性OROV病例。
研究设计与样本
- 综述,描述OROV的流行地区、传播循环、临床表现、神经侵袭性、诊断和防治。
主要发现
- 约60%感染有症状,在3至10天内出现突发发热和非特异性流感样疾病。
- 许多初始OROV感染表现类似基孔肯雅、登革和寨卡病毒感染。
- OROV感染可呈双相病程,初始症状出现约1周后症状复发。
- 类似寨卡病毒,OROV可能发生垂直传播,对胎儿发育有潜在不良影响包括流产。
- 动物模型显示OROV神经侵袭,人类已报告脑膜炎、脑炎和围感染期吉兰-巴雷综合征病例。
关键数值与推荐
- 诊断通过检测血清和/或脑脊液中OROV核酸、OROV免疫球蛋白M或OROV中和抗体。
- 无可用抗病毒治疗,目前无疫苗。
- 预防蚊和蠓叮咬是关键。
临床怎么用
- neurologists应认识并向当地/州/领地卫生部门报告任何潜在神经侵袭性OROV病例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oropouche virus (OROV) is an arthropod-borne virus (arbovirus) in the Orthobunyavirus genus and Peribunyaviridae viral family that is endemic to parts of South America, Central America, and the Caribbean. It has recently emerged in Cuba, and travel-imported cases are recently being reported in the United States and Europe. Typically maintained in a sylvatic cycle between certain forest sloths, non-human primates, birds, and mosquitoes, OROV disease outbreaks can occur in an urban cycle between certain biting midges and/or mosquitoes and humans. Clinically, approximately 60% of infections are symptomatic with an abrupt fever and non-specific influenza-like illness within 3 to 10 days. Many initial OROV infections can present similarly to chikungunya, dengue, and Zika virus infections. Interestingly, OROV infections can follow a biphasic course with recurrence of symptoms approximately 1 week after initial symptom onset. Concerningly, similar to Zika virus, it appears that vertical transmission of OROV may occur with potentially adverse effects on fetal development including miscarriages. Neuroinvasion of OROV occurs in animal models, and human cases of meningitis, encephalitis, and peri-infectious Guillain-Barré syndrome have all been reported. Diagnosis is either through detection of OROV nucleic acid, OROV immunoglobulin M, or OROV neutralizing antibodies in the serum and/or cerebrospinal fluid. No antiviral treatments are available, and there are no current vaccines. Preventing mosquito and biting midge bites is key. Neurologists should be aware of and report any potential neuroinvasive OROV disease cases to local/state/territorial health departments. ANN NEUROL 2025;97:28-33.
引用
- Pastula DM, Beckham JD, Tyler KL, et al. Oropouche Virus: An Emerging Neuroinvasive Arbovirus. Ann Neurol. 2024. PMID: 39560215. doi:10.1002/ana.27139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。